147 related articles for article (PubMed ID: 33904374)
1. Identification of selective
Sharma VK; Kathuria D; Bharatam PV
J Biomol Struct Dyn; 2022; 40(19):8687-8695. PubMed ID: 33904374
[TBL] [Abstract][Full Text] [Related]
2. Identification of Selective Inhibitors of
Sharma VK; Bharatam PV
J Comput Biol; 2021 Jan; 28(1):43-59. PubMed ID: 32207987
[TBL] [Abstract][Full Text] [Related]
3. Virtual screening, docking, and dynamics of potential new inhibitors of dihydrofolate reductase from Yersinia pestis.
Bastos Lda C; de Souza FR; Guimarães AP; Sirouspour M; Cuya Guizado TR; Forgione P; Ramalho TC; França TC
J Biomol Struct Dyn; 2016 Oct; 34(10):2184-98. PubMed ID: 26494420
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoinformatic Study on the Selective Inhibition of the Protozoan Dihydrofolate Reductase Enzymes.
Sharma VK; Abbat S; Bharatam PV
Mol Inform; 2017 Nov; 36(11):. PubMed ID: 28605138
[TBL] [Abstract][Full Text] [Related]
5. Multicomplex-based pharmacophore modeling in conjunction with multi-target docking and molecular dynamics simulations for the identification of
Manhas A; Lone MY; Jha PC
J Biomol Struct Dyn; 2019 Oct; 37(16):4181-4199. PubMed ID: 30648473
[No Abstract] [Full Text] [Related]
6. In silico screening of inhibitors against human dihydrofolate reductase to identify potential anticancer compounds.
Soofi A; Rezaei-Tavirani M; Safari-Alighiarloo N
J Biomol Struct Dyn; 2023; 41(23):14497-14509. PubMed ID: 36883866
[TBL] [Abstract][Full Text] [Related]
7. Phthalide derivatives as dihydrofolate reductase inhibitors for malaria: molecular docking and molecular dynamics studies.
Ibraheem W; Makki AA; Alzain AA
J Biomol Struct Dyn; 2023 Jul; 41(11):5127-5137. PubMed ID: 35635144
[No Abstract] [Full Text] [Related]
8. In Silico Study Identified Methotrexate Analog as Potential Inhibitor of Drug Resistant Human Dihydrofolate Reductase for Cancer Therapeutics.
Rana RM; Rampogu S; Abid NB; Zeb A; Parate S; Lee G; Yoon S; Kim Y; Kim D; Lee KW
Molecules; 2020 Jul; 25(15):. PubMed ID: 32752079
[TBL] [Abstract][Full Text] [Related]
9. Novel phytochemical-antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR.
Jayaraman P; Sakharkar KR; Lim C; Siddiqi MI; Dhillon SK; Sakharkar MK
Drug Des Devel Ther; 2013; 7():449-75. PubMed ID: 23818757
[TBL] [Abstract][Full Text] [Related]
10. Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations.
Gokhale VM; Kulkarni VM
J Comput Aided Mol Des; 2000 Jul; 14(5):495-506. PubMed ID: 10896321
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Coxiela burnetti dihydrofolate reductase via in silico docking with inhibitors and molecular dynamics simulation.
de Souza FR; Guimarães AP; Cuya T; de Freitas MP; Gonçalves ADS; Forgione P; Costa França TC
J Biomol Struct Dyn; 2017 Oct; 35(13):2975-2986. PubMed ID: 27726597
[TBL] [Abstract][Full Text] [Related]
12. Homology modelling, molecular docking, and molecular dynamics simulations reveal the inhibition of Leishmania donovani dihydrofolate reductase-thymidylate synthase enzyme by Withaferin-A.
Vadloori B; Sharath AK; Prabhu NP; Maurya R
BMC Res Notes; 2018 Apr; 11(1):246. PubMed ID: 29661206
[TBL] [Abstract][Full Text] [Related]
13. Screening of indole derivatives as the potent anticancer agents on dihydrofolate reductase: pharmaco-informatics and molecular dynamics simulation.
Abdolmaleki B; Maddah M
J Biomol Struct Dyn; 2023 May; 41(8):3667-3679. PubMed ID: 35318890
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel selective Mtb-DHFR inhibitors as antitubercular agents through structure-based computational techniques.
Sharma K; Neshat N; Sharma S; Giri N; Srivastava A; Almalki F; Saifullah K; Alam MM; Shaquiquzzaman M; Akhter M
Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900287. PubMed ID: 31867798
[TBL] [Abstract][Full Text] [Related]
15. The identification of novel Mycobacterium tuberculosis DHFR inhibitors and the investigation of their binding preferences by using molecular modelling.
Hong W; Wang Y; Chang Z; Yang Y; Pu J; Sun T; Kaur S; Sacchettini JC; Jung H; Lin Wong W; Fah Yap L; Fong Ngeow Y; Paterson IC; Wang H
Sci Rep; 2015 Oct; 5():15328. PubMed ID: 26471125
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling toward selective inhibitors of dihydrofolate reductase from the biological warfare agent Bacillus anthracis.
Giacoppo JO; Mancini DT; Guimarães AP; Gonçalves AS; da Cunha EF; França TC; Ramalho TC
Eur J Med Chem; 2015 Feb; 91():63-71. PubMed ID: 24985033
[TBL] [Abstract][Full Text] [Related]
17. Investigating the selectivity of potential new inhibitors of dihydrofolate reductase from Yersinia pestis designed by molecular modeling.
Bastos LDC; de Souza FR; Pereira Souza LM; Forgione P; Cuya T; de Alencastro RB; Pimentel AS; Celmar Costa França T
J Biomol Struct Dyn; 2019 Mar; 37(5):1170-1176. PubMed ID: 29542379
[No Abstract] [Full Text] [Related]
18. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
[TBL] [Abstract][Full Text] [Related]
19. Unveiling the Efficacy of Sesquiterpenes from Marine Sponge
Omar AM; Mohammad KA; Sindi IA; Mohamed GA; Ibrahim SRM
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770958
[TBL] [Abstract][Full Text] [Related]
20. Fragment Discovery for the Design of Nitrogen Heterocycles as Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors.
Shelke RU; Degani MS; Raju A; Ray MK; Rajan MG
Arch Pharm (Weinheim); 2016 Aug; 349(8):602-13. PubMed ID: 27320965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]